Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 68

1.

Effects of insulin monotherapy on body weight, composition, and fat distribution in newly diagnosed patients with Type 2 diabetes mellitus.

Wang H, Ni YF, Li HZ, Yang S, Feng B.

J Diabetes. 2013 Jun;5(2):146-8. doi: 10.1111/1753-0407.12026. No abstract available.

PMID:
23316885
2.

Seasonal changes in body composition and blood HbA1c levels without weight change in male patients with type 2 diabetes treated with insulin.

Sohmiya M, Kanazawa I, Kato Y.

Diabetes Care. 2004 May;27(5):1238-9. No abstract available.

PMID:
15111560
3.

Effects of insulin on body composition in patients with insulin-dependent and non-insulin-dependent diabetes.

Sinha A, Formica C, Tsalamandris C, Panagiotopoulos S, Hendrich E, DeLuise M, Seeman E, Jerums G.

Diabet Med. 1996 Jan;13(1):40-6.

PMID:
8741811
4.

Does the choice of treatment for type 2 diabetes affect the physiological response to hypoglycemia?

Peacey SR, Robinson R, Bedford C, Harris ND, Macdonald IA, Holman RR, Heller SR.

Diabetes Care. 2000 Jul;23(7):1022-3. No abstract available.

5.

Effect of insulin therapy on body fat distribution in NIDDM patients with secondary sulfonylurea failure: a preliminary report.

Takei I, Takayama S, Yamauchi A, Nakamoto S, Kitamura Y, Katsukawa F, Yamazaki H, Saruta T, Inoue S.

Eur J Clin Nutr. 1998 Feb;52(2):153-4.

PMID:
9505163
6.

Initiating basal insulin therapy in patients with type 2 diabetes mellitus.

Stoneking K.

Am J Health Syst Pharm. 2005 Mar 1;62(5):510-8. Review. No abstract available.

PMID:
15745915
7.

Causes of weight gain during insulin therapy with and without metformin in patients with Type II diabetes mellitus.

Mäkimattila S, Nikkilä K, Yki-Järvinen H.

Diabetologia. 1999 Apr;42(4):406-12.

PMID:
10230643
9.

Summaries for patients. Exenatide or insulin glargine for suboptimally controlled diabetes?

[No authors listed]

Ann Intern Med. 2005 Oct 18;143(8):I30. No abstract available. Erratum in: Ann Intern Med. 2006 Apr 18;144(8):620.

PMID:
16230718
11.

[Type 2 diabetes: hypoglycemia risk, weight gain... Will there soon be a new alternative to insulin?].

[No authors listed]

MMW Fortschr Med. 2006 Sep 14;148(37):54. German. No abstract available.

PMID:
17036907
12.

Exercise training improves glycemic control in long-standing insulin-treated type 2 diabetic patients.

De Feyter HM, Praet SF, van den Broek NM, Kuipers H, Stehouwer CD, Nicolay K, Prompers JJ, van Loon LJ.

Diabetes Care. 2007 Oct;30(10):2511-3. Epub 2007 Jul 12. No abstract available.

PMID:
17626892
13.

Efficacy of vildagliptin in combination with insulin in patients with type 2 diabetes and severe renal impairment.

Lukashevich V, Schweizer A, Foley JE, Dickinson S, Groop PH, Kothny W.

Vasc Health Risk Manag. 2013;9:21-8. doi: 10.2147/VHRM.S39300. Epub 2013 Jan 23.

14.

Hypoglycemic events and glycosylated hemoglobin values in patients with type 2 diabetes mellitus newly initiated on insulin glargine or premixed insulin combination products.

Bullano MF, Fisher MD, Grochulski WD, Menditto L, Willey VJ.

Am J Health Syst Pharm. 2006 Dec 15;63(24):2473-82.

PMID:
17158695
15.

Biphasic insulin aspart 30 treatment improves glycaemic control in patients with type 2 diabetes in a clinical practice setting: Chinese PRESENT study.

Gao Y, Guo XH, Vaz JA; PRESENT Study Group.

Diabetes Obes Metab. 2009 Jan;11(1):33-40. doi: 10.1111/j.1463-1326.2008.00904.x. Epub 2008 May 20. Erratum in: Diabetes Obes Metab. 2009 Jan;11(1):77.

PMID:
18494806
16.
17.

Effect of pramlintide on A1C and body weight in insulin-treated African Americans and Hispanics with type 2 diabetes: a pooled post hoc analysis.

Maggs D, Shen L, Strobel S, Brown D, Kolterman O, Weyer C.

Metabolism. 2003 Dec;52(12):1638-42.

PMID:
14669170
18.

PREDICTIVE- a global, prospective observational study to evaluate insulin detemir treatment in types 1 and 2 diabetes: baseline characteristics and predictors of hypoglycaemia from the European cohort.

Lüddeke HJ, Sreenan S, Aczel S, Maxeiner S, Yenigun M, Kozlovski P, Gydesen H, Dornhorst A; PREDICTIVE Study Group.

Diabetes Obes Metab. 2007 May;9(3):428-34.

PMID:
17391171
19.

Bromocriptine: a novel approach to the treatment of type 2 diabetes.

Pijl H, Ohashi S, Matsuda M, Miyazaki Y, Mahankali A, Kumar V, Pipek R, Iozzo P, Lancaster JL, Cincotta AH, DeFronzo RA.

Diabetes Care. 2000 Aug;23(8):1154-61.

20.

Combination therapies with insulin in type 2 diabetes.

Yki-Järvinen H.

Diabetes Care. 2001 Apr;24(4):758-67. Review. No abstract available.

PMID:
11315844

Supplemental Content

Support Center